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Abstract  
 
    Genetic loci explain only 25-30% of the heritability observed in plasma lipid traits. 
Epistasis, or gene-gene interactions may contribute to a portion of this missing 
heritability. Using genetic data from five NHLBI cohorts of 24,837 individuals, we 
combined the use of the quantitative multifactor dimensionality reduction (QMDR) 
algorithm with two SNP filtering methods to exhaustively search for SNP-SNP 
interactions that are associated with HDL cholesterol (HDL-C), LDL cholesterol (LDL-
C), total cholesterol (TC) and triglycerides (TG). SNPs were filtered either on the 
strength of their independent effects (main effect filter) or the prior knowledge supporting 
a given interaction (Biofilter). After the main effect filter, QMDR identified 20 SNP-SNP 
models associated with HDL-C, 6 associated with LDL-C, 3 associated with TC, and 10 
associated with TG (permutation P-value < 0.05). With the use of Biofilter, we identified 
2 SNP-SNP models associated with HDL-C, 3 associated with LDL-C, 1 associated with 
TC and 8 associated with TG (permutation P-value < 0.05). In an independent dataset of 
7,502 individuals from the eMERGE network, we replicated 14 of the interactions 
identified after main effect filtering: 11 for HDL-C, 1 for LDL-C and 2 for TG. We also 
replicated 23 of the interactions found to be associated with TG after applying Biofilter. 
Prior knowledge supports the possible role of these interactions in the genetic etiology of 
lipid traits. This study also presents a computationally efficient pipeline for analyzing 
data from large genotyping arrays and detecting SNP-SNP interactions that are not 
primarily driven by strong main effects.  
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Introduction 
 
    Plasma lipid and lipoprotein levels are a major risk factor for cardiovascular disease 
(CVD), the leading cause of death in the world (Arsenault et al. 2011; World Health 
Organization 2014). In 2012, approximately one-third of all global deaths were caused by 
CVD (Deaton et al. 2011; World Health Organization 2014). Moreover, CVD no longer 
remains a disease associated with industrialized nations. With increasing urbanization 
around the world, 80% of global CVD-related deaths occur in low- and middle-income 
countries and the World Health Organization estimates global CVD-related deaths to 
reach 22.2 million by 2030 (World Health Organization 2014). 
 
    Although lipid levels can be influenced by factors such as age, sex, body mass index 
(BMI), environmental factors and lifestyle choices including diet, they can be influenced 
by genetic factors as well (Heller et al. 1993). Lipid traits such as high density lipoprotein 
cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) 
and triglyceride (TG) levels have been shown to have heritability estimates ranging 
between 40% to 60% (Weiss et al. 2006).  
 
  Various genetic loci associated with lipid traits have been identified by genome-wide 
association studies (GWAS); however, these loci only explain 25-30% of the heritability 
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observed in plasma lipid traits (Kathiresan et al. 2009; Teslovich et al. 2010). Epistasis, 
or interactions between genes, may help to explain a portion of the missing heritability of 
lipid traits (Manolio et al. 2009) and studies are needed to examine the genomic context 
of single nucleotide polymorphisms (SNPs) by specifically searching for non-linear 
interactions between them (Eichler et al. 2010). 
 
    Exhaustively searching for interactions between SNPs in large datasets generated with 
genotyping arrays leads to a prohibitive number of statistical tests and is computationally 
expensive (Moore et al. 2010). In this study, we addressed these bioinformatics 
challenges by applying SNP-filtering methods along with the quantitative multifactor 
dimensionality reduction (QMDR) machine learning algorithm to the analysis of lipid 
traits for the first time. We aimed to identify interactions between SNPs that are 
associated with four lipids traits (HDL-C, LDL-C, TC and TG) across five National 
Heart, Lung and Blood Institute (NHLBI) study cohorts. These SNPs have also been 
analyzed as part of a previous large-scale study aimed at identifying independent signals 
associated with multiple lipid traits using regression methods. This study identified 21 
novel loci that had not been found to be associated with lipid traits before. The study also 
replicated a large number of previously implicated signals associated with lipid traits 
(Asselbergs et al. 2012).   
 
Results 
 
Main effect filter 
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    The main effect filter resulted in a final list of 486 markers to be tested for SNP-SNP 
interactions for HDL-C, 462 markers for LDL-C, 571 markers for TC and 502 markers 
for TG. After QMDR analysis, at a permutation P-value  < 0.05, we identified 20 SNP-
SNP interaction models that were associated with HDL-C (Table 1), 6 SNP-SNP 
interaction models associated with LDL-C (Table 2), 3 SNP-SNP interaction models 
associated with TC (Table 3), and 10 SNP-SNP models associated with TG (Table 4).  
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Table 1 Results from QMDR association analysis of Main effect filter SNPs for HDL Cholesterol levels 
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted 
P-Value 
1 rs4783961,rs1800775 rs4783961 16:55552395 CETP rs1800775 16:55552737 CETP < 0.00001 
2 rs12720918,rs158477 rs12720918 16:55551713 CETP rs158477 16:55565111 CETP < 0.00001 
3 rs4783961,rs1864163 rs4783961 16:55552395 CETP rs1864163 16:55554734 CETP < 0.00001 
4 rs12720918,rs4783961 rs12720918 16:55551713 CETP rs4783961 16:55552395 CETP < 0.00001 
5 rs1864163,rs4784744 rs1864163 16:55554734 CETP rs4784744 16:55568686 CETP < 0.00005 
6 rs12708967,rs820299 rs12708967 16:55550712 CETP rs820299 16:55557785 CETP < 0.00024 
7 rs12447924,rs9939224 rs12447924 16:55551693 CETP rs9939224 16:55560233 CETP < 0.00031 
8 rs4783961,rs158477 rs4783961 16:55552395 CETP rs158477 16:55565111 CETP < 0.00087 
9 rs1864163,rs158477 rs1864163 16:55554734 CETP rs158477 16:55565111 CETP < 0.00104 
10 rs1864163,rs820299 rs1864163 16:55554734 CETP rs820299 16:55557785 CETP 0.00405 
11 rs4783961,rs9939224 rs4783961 16:55552395 CETP rs9939224 16:55560233 CETP < 0.00525 
12 rs1800775,rs820299 rs1800775 16:55552737 CETP rs820299 16:55557785 CETP < 0.0083 
13 rs12744291,rs1010554 rs12744291 1:66135559 PDE4B rs1010554 3:52517959 STAB1 < 0.00873 
14 rs230541,rs4935047 rs230541 4:103716823 NFKB1 rs4935047 10:54200073 MBL2 0.01116 
15 rs12976922,rs2952101 rs12976922 19:60562163 COX6B2 rs2952101 X:14768515 FANCB < 0.0119 
16 rs9644636,rs7013777 rs9644636 8:19869176 LPL rs7013777 8:19922636 LPL < 0.01719 
17 rs9939224,rs4784744 rs9939224 16:55560233 CETP rs4784744 16:55568686 CETP 0.01843 
18 rs599839,rs2952101 rs599839 1:109623689 PSRC1 rs2952101 X:14768515 FANCB 0.02954 
19 rs12708967,rs158477 rs12708967 16:55550712 CETP rs158477 16:55565111 CETP 0.03023 
20 rs3870336,rs6641322 rs3870336 3:49532861 DAG1 rs6641322 X:149494622 IDS < 0.04418 
20 signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). 
SNP1 and SNP2 indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in 
the following format - Chromosome:Base pair. P-values were calculated from a distribution built from 1000 permutations. 
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Table 2 Results from QMDR association analysis of Main effect filter SNPs for LDL cholesterol levels  
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted P-
Value 
1 rs157580,rs439401 rs157580 19:50087106 TOMM40 rs439401 19:50106291 APOE < 0.00522 
2 rs17435152,rs3764261 rs17435152 7:40568630 C7orf10 rs3764261 16:55550825 CETP 0.00743 
3 rs157580,rs405509 rs157580 19:50087106 TOMM40 rs405509 19:50100676 APOE 0.00781 
4 rs12811752,rs1469713 rs12811752 12:20469072 PDE3A rs1469713 19:19389806 GATAD2A < 0.01293 
5 rs480780,rs2965174 rs480780 13:32505319 KL rs2965174 19:49936855 BCL3 0.02482 
6 rs625619,rs3764261 rs625619 1:55290754 PCSK9 rs3764261 16:55550825 CETP 0.03809 
6 signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). SNP1 
and SNP2 indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in the 
following format - Chromosome:Base pair. P-values were calculated from a distribution built from 1000 permutations. 
Table 3 Results from QMDR association analysis of Main effect filter SNPs for total cholesterol levels 
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted P-
Value 
1 rs693,rs661665 rs693 2:21085700 APOB rs661665 2:21118646 APOB < 0.00835 
2 rs12898801,rs953065 rs12898801 15:56585846 LIPC rs953065 15:87203929 ACAN < 0.01297 
3 rs10744777,rs749767 rs10744777 12:110717401 ALDH2 rs749767 16:31031908 BCKDK 0.01975 
3 signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). SNP1 
and SNP2 indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in the 
following format - Chromosome:Base pair. P-values were calculated from a distribution built from 1000 permutations. 
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Table 4 Results from QMDR association analysis of Main effect filter SNPs for triglyceride levels 
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted 
P-Value 
1 rs2075295,rs6589568 rs2075295 11:116133611 BUD13 rs6589568 11:116175948 APOA5 < 0.00001 
2 rs4938303,rs180327 rs4938303 11:116090197 BUD13 rs180327 11:116128869 BUD13 < 0.00001 
3 rs180327,rs2075295 rs180327 11:116128869 BUD13 rs2075295 11:116133611 BUD13 < 0.00007 
4 rs180327,rs10750097 rs180327 11:116128869 BUD13 rs10750097 11:116169250 APOA5 < 0.00027 
5 rs11216129,rs10750097 rs11216129 11:116125466 BUD13 rs10750097 11:116169250 APOA5 < 0.00516 
6 rs609526,rs12257915 rs609526 1:228375529 GALNT2 rs12257915 10:90982709 LIPA < 0.03321 
7 rs2075295,rs10750097 rs2075295 11:116133611 BUD13 rs10750097 11:116169250 APOA5 < 0.03351 
8 rs4938303,rs6589568 rs4938303 11:116090197 BUD13 rs6589568 11:116175948 APOA5 < 0.03379 
9 rs174455,rs689243 rs174455 11:61412693 FADS3 rs689243 11:116227903 KIAA0999 < 0.03789 
10 rs180327,rs618923 rs180327 11:116128869 BUD13 rs618923 11:116159369 ZNF259 < 0.03833 
 
10 signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). 
SNP1 and SNP2 indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in 
the following format - Chromosome:Base pair. P-values were calculated from a distribution built from 1000 permutations.  
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     In the case of HDL-C, a large number of the identified SNP-SNP models represent 
intra-genic interactions within CETP. Fig. 1 shows the underlying LD structure of these 
interactions. None of the interacting SNPs were in strong LD (r2 > 0.8). Moreover, none 
of the identified pairwise interactions for each of the quantitative lipid traits exhibited 
strong LD (Figs. S1-3). 
 
Biofilter 
 
    The Biofilter procedure resulted in a final list of 1,811 markers (22,487 SNP-SNP 
models) for HDL-C, 1,812 markers (22,491 SNP-SNP models) for LDL-C, 1,812 
markers (22,454 SNP-SNP models) for TC and 1,811 markers (22,487 SNP-SNP models) 
for TG. QMDR analysis identified 14 significant SNP-SNP models with a permutation P-
value < 0.05: 2 SNP-SNP models associated with HDL-C, 3 SNP-SNP models associated 
with LDL-C, 1 SNP-SNP model associated with TC and 8 SNP-SNP models associated 
with TG (Table 5). None of the interacting SNPs were found to be in strong LD in this 
case as well (Figs. S4-7).  
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Table 5 Results from QMDR association analysis of Biofilter SNPs for lipid traits 
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted 
P-Value 
HDL Cholesterol Levels 
1 rs17496549,rs615672 rs17496549 6:32517686 HLA-DRA rs615672 6:32682149 HLA-DRB1 < 0.01178 
2 rs549888,rs7240326 rs549888 6:33660180 GGNBP1 rs7240326 18:59068331 BCL2 0.0404 
LDL Cholesterol Levels 
1 rs39499,rs751919 rs39499 8:90839744 RIPK2 rs751919 16:49333246 CYLD 0.03262 
2 rs12693591,rs8072566 rs12693591 2:191568747 STAT1 rs8072566 17:37729889 STAT3 0.04211 
3 rs2066795,rs8074524 rs2066795 2:191560142 STAT1 rs8074524 17:37723124 STAT3 < 0.04788 
Total Cholesterol Levels 
1 rs4725431,rs10875915 rs4725431 7:151104112 PRKAG2 rs10875915 12:47716361 MLL2 < 0.04276 
Triglyceride Levels 
1 rs9521510,rs2860184 rs9521510 13:109224872 IRS2 rs2860184 19:7238748 INSR < 0.00079 
2 rs9521510,rs6510976 rs9521510 13:109224872 IRS2 rs6510976 19:7217944 INSR < 0.00289 
3 rs2075110,rs4789172 rs2075110 7:55186653 EGFR rs4789172 17:70853307 GRB2 < 0.00385 
4 rs4773088,rs4804404 rs4773088 13:109219885 IRS2 rs4804404 19:7169382 INSR < 0.00401 
5 rs7999797,rs8109559 rs7999797 13:109224001 IRS2 rs8109559 19:7122629 INSR 0.01758 
6 rs4771646,rs4804404 rs4771646 13:109225180 IRS2 rs4804404 19:7169382 INSR < 0.02007 
7 rs1729409,rs11216162 rs1729409 11:116178978 APOA5 rs11216162 11:116233487 KIAA0999 < 0.02063 
8 rs7999797,rs7252268 rs7999797 13:109224001 IRS2 rs7252268 19:7121505 INSR < 0.03164 
 
Signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). SNP1 
and SNP2 indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in the 
following format - Chromosome:Base pair. P-values were calculated from a distribution built from 1000 permutations.  
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Replication analyses 
 
    After following an identical QMDR analysis procedure, we were able to replicate 
SNP-SNP models in the eMERGE dataset at a permutation P-value threshold of 0.05. 
Eleven main effect filtered SNP-SNP models were replicated for HDL-C, 1 main effect 
filtered SNP-SNP model for LDL-C and 2 such models for TG (Table 6).  Additionally, 
23 Biofilter SNP-SNP models replicated for TG (Table 6).  
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Table 6 Results from QMDR association analysis of main effect and Biofilter SNP-SNP models replicated in eMERGE dataset  
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted 
P-Value 
Main effect filter: HDL Cholesterol Levels 
1 rs4783961,rs1800775 rs4783961 16:55552395 CETP rs1800775 16:55552737 CETP < 0.00001 
2 rs4783961,rs3816117 rs4783961 16:55552395 CETP rs3816117 16:55553659 CETP < 0.00001 
3 rs4783961,rs1532624 rs4783961 16:55552395 CETP rs1532624 16:55562980 CETP < 0.00001 
4 rs4783961,rs1532625 rs4783961 16:55552395 CETP rs1532625 16:55562802 CETP < 0.00001 
5 rs4783961,rs7205804 rs4783961 16:55552395 CETP rs7205804 16:55562390 CETP < 0.00001 
6 rs4783961,rs711752 rs4783961 16:55552395 CETP rs711752 16:55553712 CETP < 0.00001 
7 rs4783961,rs708272 rs4783961 16:55552395 CETP rs708272 16:55553789 CETP < 0.00001 
8 rs1864163,rs289717 rs1864163 16:55554734 CETP rs289717 16:55566889 CETP < 0.00004 
9 rs1864163,rs4784744 rs1864163 16:55554734 CETP rs4784744 16:55568686 CETP < 0.00004 
10 rs1864163,rs291044 rs1864163 16:55554734 CETP rs291044 16:55568953 CETP < 0.00004 
11 rs4783961,rs1864163 rs4783961 16:55552395 CETP rs1864163 16:55554734 CETP < 0.00229 
Main effect filter: LDL Cholesterol Levels 
1 rs157580,rs405509 rs157580 19:50087106 TOMM40 rs405509 19:50100676 APOE < 0.00488 
Main effect filter: Triglyceride Levels 
1 rs180327,rs618923 rs180327 11:116128869 BUD13 rs618923 11:116159369 ZNF259 < 0.31483 
2 rs180326,rs618923 rs180326 11:116129913 BUD13 rs618923 11:116159369 ZNF259 < 0.33204 
Biofilter: Triglyceride Levels 
1 rs9521510,rs6510976 rs9521510 13:109224872 IRS2 rs6510976 19:7217944 INSR < 0.01014 
2 rs35612086,rs6510976 rs35612086 13:109244865 IRS2 rs6510976 19:7217944 INSR < 0.01155 
3 rs36092351,rs6510976 rs36092351 13:109246741 IRS2 rs6510976 19:7217944 INSR < 0.01163 
4 rs2117455,rs6510976 rs2117455 13:109241895 IRS2 rs6510976 19:7217944 INSR < 0.01166 
5 rs9521517,rs6510976 rs9521517 13:109245638 IRS2 rs6510976 19:7217944 INSR < 0.01166 
6 rs1414316,rs6510976 rs1414316 13:109248190 IRS2 rs6510976 19:7217944 INSR < 0.01168 
7 rs9521510,rs6510975 rs9521510 13:109224872 IRS2 rs6510975 19:7217878 INSR < 0.01259 
14 
8 rs9515119,rs6510975 rs9515119 13:109207337 IRS2 rs6510975 19:7217878 INSR < 0.01643 
9 rs9515119,rs6510976 rs9515119 13:109207337 IRS2 rs6510976 19:7217944 INSR < 0.01657 
10 rs2289046,rs6510975 rs2289046 13:109205907 IRS2 rs6510975 19:7217878 INSR < 0.01657 
11 rs2289047,rs6510975 rs2289047 13:109205816 IRS2 rs6510975 19:7217878 INSR < 0.01657 
12 rs2289046,rs6510976 rs2289046 13:109205907 IRS2 rs6510976 19:7217944 INSR 0.01680 
13 rs2289047,rs6510976 rs2289047 13:109205816 IRS2 rs6510976 19:7217944 INSR 0.01680 
14 rs4771649,rs6510976 rs4771649 13:109248514 IRS2 rs6510976 19:7217944 INSR < 0.01709 
15 rs35612086,rs6510975 rs35612086 13:109244865 IRS2 rs6510975 19:7217878 INSR < 0.02214 
16 rs36092351,rs6510975 rs36092351 13:109246741 IRS2 rs6510975 19:7217878 INSR < 0.02220 
17 rs2117455,rs6510975 rs2117455 13:109241895 IRS2 rs6510975 19:7217878 INSR < 0.02223 
18 rs9521517,rs6510975 rs9521517 13:109245638 IRS2 rs6510975 19:7217878 INSR 0.02223 
19 rs1414316,rs6510975 rs1414316 13:109248190 IRS2 rs6510975 19:7217878 INSR < 0.02225 
20 rs2075110,rs4789172 rs2075110 7:55186653 EGFR rs4789172 17:70853307 GRB2 < 0.02793 
21 rs4771649,rs6510975 rs4771649 13:109248514 IRS2 rs6510975 19:7217878 INSR 0.03304 
22 rs2075109,rs4789172 rs2075109 7:55186397 EGFR rs4789172 17:70853307 GRB2 0.04293 
23 rs9521518,rs6510976 rs9521518 13:109251997 IRS2 rs6510976 19:7217944 INSR 0.04882 
 
Shown here are models that reached a permutation P-value < 0.05 in the replication dataset. SNPs have been mapped to their 
corresponding genes using dbSNP (build 139). SNP1 and SNP2 indicate the individual SNPs within a given SNP-SNP interaction 
model. . Chromosomal location of SNPs is noted in the following format - Chromosome:Base pair.  P-values were calculated from a 
distribution built from 1000 permutations.  
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Discussion 
 
    Although many researchers acknowledge the need for embracing the complexity of the 
genotype-phenotype relationship by studying gene-gene interactions, exploring epistasis 
in large genotyping arrays presents a biostatistical and computational challenge. These 
challenges call for new computational methods since more traditional approaches such as 
general linear models may have limited power when modeling high-dimensional data. 
The use of SNP-filtering methods has been presented as a suitable solution to ease the 
computational burden of exhaustively searching for all possible interactions between 
large numbers of SNPs (Moore et al. 2010).  
 
    In our analyses, we combined genotypic and phenotypic information for four 
quantitative lipid traits – HDL-C, LDL-C, TC and TG – for 24,837 individuals from five 
study cohorts. We reduced the number of interactions tested by filtering SNPs either 
based on the strength of their independent effects or the strength of relevant prior 
biological knowledge. Filtered SNPs were tested for two-way SNP-SNP interactions 
associated with each quantitative lipid trait using QMDR.  
 
    Below we highlight the potential biological functions for several genes at or near the 
identified interacting SNPs. Further details regarding the biological roles and functions 
associated with all genes at or near these interactions are listed in Table S1.  
 
HDL-C 
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      In our analysis, the 25 total SNPs that we identified to interact significantly with each 
other, were in or near 15 genes. Ten SNPs were located at or near CETP, which is 
involved in the transfer of cholesteryl ester from HDL to other lipoproteins (Barter et al. 
2003). Moreover, we identified 12 intra-genic interactions between independent SNPs 
within the CETP region (Table 1). Three of the original intra-genic CETP interactions 
(interactions 1, 9 and 11 in Table 6) and 8 additional LD expanded interactions were 
replicated in the eMERGE dataset. Though the impact of these intra-genic regions on 
HDL-C is unknown, they may act through regulatory or epigenetic mechanisms (Soto-
Ramírez et al. 2013; Olsson et al. 2014). 
 
    Some of the other identified genes also have well studied roles in lipid and cholesterol 
metabolism such as – LPL and PSRC1 (Brown et al. 1989; Kuivenhoven et al. 1997). 
Both genes were identified in interactions in the discovery dataset only. Two SNPs were 
at or near LPL; mutations in LPL are linked to various disorders of lipoprotein 
metabolism and have been previously reported to alter HDL-C levels (Reymer et al. 
1995; Wittekoek et al. 1998). We also identified one intra-genic interaction within LPL 
(Table 1). Lastly, 1 SNP was near PSRC1. Variations within PSRC1 have also been 
shown be associated with cholesterol traits in previous GWA studies (Kathiresan et al. 
2008a; Ma et al. 2010; Voight et al. 2012).  
 
     The IMP network of genes represented in main effect filtered SNP-SNP models 
associated with HDL-C, includes genes from replicated and non-replicated interactions. 
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The interaction between PSRC1 with BRCA1 via AURKA in this network, highlights a 
potentially interesting biological connection between dyslipidemia and breast cancer (Fig. 
2). High cholesterol has been highlighted as a risk factor for breast cancer and various 
mechanisms linking the two diseases have been hypothesized and studied (Nelson et al. 
2014). The interaction between PSRC1 and AURKA in this network reflects their well-
known role in spindle organization. There was also strong support for the interaction 
between AURKA and BRCA1. This is not surprising since, AURKA is a known to be an 
activator of Akt (Yao et al. 2009) – a kinase involved in tumor cell growth (Paplomata 
and O’Regan 2014).  
 
LDL-C 
 
    We identified 16 total SNPs to interact significantly with each other, located in or near 
13 genes. These findings included two SNP-SNP models representing interactions 
between the genes TOMM40 and APOE. One of these interaction models replicated in the 
eMERGE dataset (Table 6). The TOMM40/APOE-C1-C2-C4 gene cluster has been 
shown to affect LDL-C levels previously (Klos et al. 2008; Middelberg et al. 2011). In 
the IMP network built from SNP-SNP models identified after main effect filtering, there 
is strong support for the interaction between TOMM40 and FARSA, which encodes for 
the alpha subunit of a phenylalanyl-tRNA synthetase (Fig. 3). FARSA is also involved in 
a protein-protein interaction with the ECSIT signaling integrator, which in turn interacts 
with APOE. Furthermore, APOE interacts with LDLR in the network, highlighting their 
shared role in sterol transport and cholesterol homeostasis (Fig. 3). LDLR, which encodes 
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for the LDL receptor, also interacts with PCSK9 in the network since both genes share a 
role in cholesterol homeostasis (Fig. 3). PCSK9 binds LDLR and promotes degradation 
of the LDL receptor either in the lysosome or in the liver (Cao et al. 2011). Hence, due to 
its inhibitory role with LDLR, it has emerged as an attractive drug target for 
hypercholesterolemia (Akram et al. 2010).  
 
    The IMP network also had an enrichment of processes such as - cholesterol and lipid 
homeostasis, cholesterol transport, regulation of plasma lipoprotein particle levels, 
plasma lipoprotein particle clearance, and low density lipoprotein particle receptor 
catabolic process. The genes involved in these processes included APOE, CETP and 
PCSK9. SNPs within these genes have been previously found to be associated with LDL-
C (Talmud et al. 2009).  
 
Total Cholesterol 
 
    There were 3 SNP-SNP interactions that were significantly associated with TC after 
main effect filtering. An intra-genic interaction within APOB was most significantly 
associated with TC after main effect filtering, although it did not replicate in the 
eMERGE dataset. Mutations within APOB can cause familial defective apolipoprotein B-
100 (FDB) – an inherited form of hypercholesterolemia (Hooper et al. 2005). The protein 
encoded by this gene forms the building block for various types of low-density 
lipoproteins. It is also involved in cholesterol homeostasis and sterol transport. 
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Researchers have also found a polymorphism on this gene to increase LDL-C levels 
(Benn et al. 2005).  
 
    There was one significant SNP-SNP interaction associated with TC after Biofilter 
filtering which also did not replicate in the eMERGE dataset. The gene-gene interaction 
between MLL2 and PRKAG2 highlights biological processes such as histone methylation, 
protein alkylation and protein methylation (Wong et al. 2012). MLL2 codes for a mixed-
lineage leukemia histone methylase which contributes to the activation of SR-B1 – a 
class-B type-1 scavenger receptor responsible for maintaining blood cholesterol levels 
(Ansari et al. 2012). PRKAG2 encodes for the regulatory γ2 subunit of an AMP-activated 
protein kinase. Homozygotes of an intronic SNP within PRKAG2 have been found to 
have elevated serum concentrations of TC and TG (Xu et al. 2005).  
 
Triglycerides 
 
    We found an interaction between BUD13 and ZNF259. This interaction and an LD-
expanded SNP-SNP model representing it were replicated in the eMERGE dataset (Table 
6). An interaction between variants on these two genes has been found to be associated 
with TG and TC before (Aung et al. 2014). Moreover, many studies have found 
polymorphisms within BUD13 to be associated with TG (Kathiresan et al. 2008b; 
Waterworth et al. 2010; Aung et al. 2014). BUD13 encodes for the BUD13 homolog 
protein. It is part of the RES complex that was originally identified as a splicing factor in 
yeast and shown to affect nuclear pre-mRNA retention (Brooks et al. 2009).  
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    Six of the eight SNP-SNP interactions associated with TG after Biofilter filtering, 
represent an interaction between the genes INSR and IRS2. Twenty-one models 
representing this SNP-SNP interaction were identified in the eMERGE dataset as well 
(Table 6). This included two of the original SNP-SNP interactions between these genes 
(interactions 1 and 20 in Table 6). INSR encodes for the insulin receptor, which works 
with the IRS2 molecule in hepatic insulin signaling. Insulin is also known to activate 
lipogenesis within the liver. Moreover, an inverse relationship between IRS2 and SREBP-
1 gene expression has been demonstrated (Ide et al. 2004). SREBPs are transcription 
factors that are involved in the expression of various genes involved in the synthesis of 
triglycerides (Horton et al. 2002).  
 
Strengths and Limitations 
 
    Despite the computational and biostatistical challenges of investigating gene-gene 
interactions in datasets from large genotyping arrays, we have established an efficient 
analytic framework to overcome the limited power of traditional statistical methods when 
modeling high-dimensional data. The use of knowledge-based filtering methods within 
our framework improved our ability to identify biologically relevant interactions in the 
context of lipid phenotypes. 
 
    However, our methods are limited by the strength of the knowledge of gene functions 
available in public databases. Additionally, our replication sample was small which could 
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have decreased our power to replicate the interactions we identified in our discovery 
dataset. Lastly, although the use of SNP-filtering methods have been suggested as a 
favorable solution for reducing the computational burden of studying epistasis in such 
large datasets, they do introduce their own biases into the study, which have been 
discussed previously (Ritchie 2011).  
 
    The use of traditional statistical methods focusing on main effects has been able to 
explain only a portion of the heritability of lipid traits. We performed a comprehensive 
analysis by examining gene-gene interactions within four quantitative lipid traits – HDL-
C, LDL-C, TC and TG, from five study cohorts. With the use of machine learning 
algorithms such as QMDR, a targeted gene-centric genotypic chip and SNP-filtering 
methods, we identified multiple gene-gene interactions associated with these lipid traits. 
Existing knowledge suggests potentially important roles for these genes in the 
pathobiology of lipid traits. Ultimately, the true effect of these interactions will have to be 
validated through targeted functional studies at the bench.  
 
Subjects and Methods 
 
Participating Cohorts 
 
   The overall study design is shown in Fig. 4. Genotype and phenotype information was 
combined from the following studies: Atherosclerosis Risk in Communities (ARIC) (Hill 
et al. 1989); Coronary Artery Risk Development in Young Adults (CARDIA) (Friedman 
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et al. 1988); Cardiovascular Health Study (CHS) (Fried et al. 1991); Framingham Heart 
Study (FHS) (Dawber et al. 1951); and Multi-Ethnic Study of Atherosclerosis (MESA) 
(Bild et al. 2002) (Table S2), resulting in an initial sample size of 24,837 individuals of 
self-reported European ancestry. 
 
    The eMERGE I-660 dataset was used for replication analyses (McCarty et al. 2011). 
This dataset was imputed using data from the 1000 Genomes Project (Verma et al. 2014). 
Detailed information regarding the replication dataset is presented in Table S3. 
 
Phenotypic outcomes measured 
 
     HDL-C, LDL-C, TC and TG levels were measured from baseline or first measurement 
blood samples. All measurements were converted to mmol/L. LDL-C was calculated 
according to Friedewald’s formula (Friedewald et al. 1972):  
L ~ C – H – kT 
 
where C is total cholesterol, H is HDL, L is LDL, T is triglycerides, and k is 0.45 for 
mmol/L. If TG values were > 4.51 mmol/L, then LDL was treated as a missing value. 
Additionally, TG values were transformed for normality.  
 
Genotyping and quality control 
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     Study participants in the discovery dataset were genotyped using the gene-centric 
ITMAT-Broad-CARe (IBC) array. The IBC array contains 47, 451 SNPs and it was 
designed to test ~ 2,100 loci that have been implicated in various cardiovascular, 
metabolic and inflammatory phenotypes (Keating et al. 2008). SNPs with a genotype 
missing rate greater than 95%, with an exact test of Hardy-Weinberg equilibrium P-value 
< 1.0 x 10-7 or a minor allele frequency (MAF) < 0.05 were excluded. Samples with a 
genotype missing rate greater than 90% were also excluded. This reduced our dataset to 
24, 837 individuals and 44,570 SNPs.  
 
     Non-founder individuals were also removed from the study population. To check for 
relatedness between individuals, identity-by-descent (IBD) estimates were calculated 
using PLINK (Purcell et al. 2007). For each pair of individuals with a ?̂? > 0.3, one 
individual was removed.  
 
     Finally, individual datasets with no missing phenotype data were created for each of 
the lipid outcomes measured. Within each of the datasets, SNPs were further tested for 
linkage disequilibrium (LD) – a SNP was removed from each pair of SNPs that had an 
LD (r2) ≥ 0.6. Genotypes were also imputed, to ensure there was no missing genotype 
information. The most common genotype for a given marker was used as the imputed 
genotype. Further details of the number of SNPs and individuals in each of these datasets 
can be found in Fig. 4.  
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    Study participants in the replication dataset were from the eMERGE network.  The 
eMERGE network is a consortium of institutions with DNA from biorepositories linked 
to data from patient electronic medical records (EMR) (Gottesman et al. 2013).  The 
eMERGE set was genotyped with the Illumina660W GWAS platform and further 
imputed using 1000 Genomes project data, as described previously (Verma et al. 2014).  
The replication set consisted of data from the Marshfield Clinic, Northwestern 
University, Group Health Cooperative, Mayo Clinic, and Vanderbilt University. After 
QC, the final eMERGE sample size was n=7,502 for all lipid traits. Details on quality 
control and phenotype extractions from the EMR have been published previously 
(Rasmussen-Torvik et al. 2012).  Briefly, each cohort tested for population stratification 
and relatedness, adjusting accordingly. The minimum variant and sample call rate 
threshold for all replication cohorts was 0.95 and 0.90, respectively. A Hardy-Weinberg 
equilibrium test P-value threshold of at least P < 1 x 10-6 was applied by each group. 
 
Marker Selection 
 
    To reduce the computational time burden and multiple hypothesis testing, additional 
parallel SNP filtering steps (main effect filter and Biofilter) were employed. These 
strategies have been implemented by other studies as two powerful options for gene-gene 
interaction analysis in large-scale genotype datasets (Sun et al. 2014).   
 
 
Main Effect Filter 
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     SNPs were tested for their independent association with the continuous lipid outcome 
using linear regression (Asselbergs et al. 2012). SNPs with a main effect P-value < 0.01 
were selected for further analysis.  
 
Biofilter 
 
    SNPs were also analyzed using Biofilter 2.0, a knowledge-based software package that 
enables the analysis and identification of multi-SNP models in large datasets (Bush et al. 
2009; Pendergrass et al. 2013). It has previously been used to identify predictive SNP-
SNP models for traits such as age-related cataract (Hall et al. 2015), multiple sclerosis 
(Bush et al. 2011), HIV pharmacogenetics (Grady et al. 2011) and HDL cholesterol 
(Turner et al. 2011). The software combines information from various online public 
knowledge databases to identify genes and SNPs that are most likely to interact with each 
other through their mutual participation in biological processes, signaling pathways and 
protein-protein interactions. Biofilter also provides an implication index, which measures 
the strength of the knowledge-based support for a putative interaction model. This is 
indicated by the sum of the number of supporting data sources for each of the genes in a 
given interaction. In our analyses, we included models if they were supported by at least 
five sources. This was a slightly more stringent implication index cut-off than those used 
in previous studies (Turner et al. 2011).  
 
Statistical Analyses 
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Covariate Adjustment 
 
     Quantitative lipid outcome values were regressed on age, sex, BMI, use of 
medications for lowering lipids, first ten principal components addressing population 
substructure, type II diabetes status and smoking status. The residual lipid outcome 
values from this regression model were then used as the continuous phenotypic outcome 
variable in QMDR analysis. Principal components were computed using the 
EIGENSTRAT software (Price et al. 2006)) 
 
Association Analysis using QMDR 
 
     SNPs obtained from the filtering procedures described above were tested for 
association with the corresponding continuous lipid outcome using QMDR. QMDR is an 
extension of the two-class MDR algorithm used to detect and characterize multi-SNP 
interactions in the context of a quantitative trait (Ritchie et al. 2001; Gui et al. 2013).  
 
    Originally, the MDR algorithm was designed as a data reduction method to enable the 
identification of multi-locus genotype combinations that are associated with high or low 
risk of a disease (Ritchie et al. 2001). For a dataset of m SNPs, k SNPs can be selected to 
study a k-order interaction. Next, a contingency table is constructed and case-control 
ratios are calculated for each of the possible multi-locus genotypes for these k SNPS. The 
case-control ratio for each multi-locus genotype is then compared to the case-control ratio 
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for the whole dataset. If the genotype-specific case-control ratio exceeds the case-control 
ratio for the dataset, it is considered to be high-risk, otherwise it is considered to be low-
risk.  
 
    However, in the case of QMDR, the algorithm compares the mean value of the 
phenotype for a specific multi-locus genotype, to the overall mean of the phenotype 
within the entire dataset. Consequently, a genotype combination is considered high-level 
if its mean phenotype value is larger than the overall mean of the phenotype. Otherwise, 
it is considered low-level. Finally, QMDR combines the ‘high-level’ and ‘low-level’ 
genotypes into separate groups and compares the phenotypic outcomes between these 
two groups using a T-test.  
 
    QMDR also involves a 10-fold cross-validation procedure similar to the original MDR 
algorithm. The data is divided into 10 portions – 9 portions are used as a training dataset 
and the remaining portion is used as a testing dataset. The algorithm repeats the 
procedure described above and calculates the overall mean of the phenotype separately 
for the training and the testing dataset. The training t-statistic is calculated for each k-way 
interaction in the training dataset. Next, the k-way model with the best training score is 
used to predict the case-control status in the testing dataset. The training t-statistic score 
is used to choose the best k-order interaction model and the highest testing t-statistic is 
used to select the best interaction model for the dataset.  
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    In our analyses, we used QMDR to analyze filtered SNPs for all possible SNP-SNP 
interaction models that are associated with a given continuous lipid outcome (HDL-C, 
LDL-C, TC and TG) based on their training t-statistic scores. Amongst these models, the 
100 best overall SNP-SNP models were selected using their testing t-statistic scores. 
Additionally, we used linear regression to adjust for the main effect of each SNP within a 
SNP-SNP model tested by QMDR. This was performed to increase our ability to identify 
pairwise interactions that are not primarily driven by the strong independent effects of the 
participating SNPs within a model. 
 
Permutation testing to assess statistical significance 
 
     We also performed 1000 permutations to establish a null distribution and determine 
the threshold for an α=0.05 significance level. Identical to our analysis procedure, the 100 
best SNP-SNP models were selected based on their t-statistic training and testing values 
for each permuted dataset. The null distribution built from the 100 best SNP-SNP models 
from all permutations and their corresponding t-statistic values was utilized to calculate 
P-values.  
 
Mapping SNPs to genes 
 
    SNPs within the statistically significant pairwise interactions for each quantitative lipid 
trait were mapped to a corresponding gene using dbSNP (build 139) and SCANdb 
(www.scandb.org).  
29 
 
Integrated Multi-Species Prediction (IMP) web server 
 
    We also used the Integrated Multi-Species Prediction (IMP) web server to query genes 
represented by the SNPs within identified interactions (Wong et al. 2012). IMP integrates 
biological evidence from multiple information sources such as experimentally verified 
information from gene expression studies, IntAct, MINT, MIPS, and BioGRID databases. 
The software mines empirical data to provide a probability score that two genes are 
involved in a functional and biological relationship. 
 
Replication Analyses 
 
    SNP-SNP models with a permutation P-value < 0.05 were chosen for replication in the 
eMERGE dataset (McCarty et al. 2011). We also identified all SNP-SNP models that 
were in LD with the identified significant models. SNPs that are in high LD (r2 > 0.8) 
with the SNPs in the interaction models, were identified using SNAP (Johnson et al. 
2008). This data was used to generate a list of ‘proxy’ SNP-SNP models representing the 
original significant interaction models. Both the statistically significant original models 
and the proxy models representing them were tested for replication. Table S4 shows the 
number of models tested per lipid quantitative trait. Additional details of the number of 
LD expanded models generated and tested for each original model are presented in Table 
S5. The same QMDR analysis procedure was performed as described earlier.  
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Figure Captions 
 
Fig. 1 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with HDL cholesterol 
level. LD diagram was generated using Haploview. Interactions between SNPs are shown 
with dotted lines. SNPs were mapped to corresponding genes using dbSNP (build 139) 
and SCANdb. (rs2952101 and rs6641322 on chromosome X are not shown here) 
 
Fig. 2 Functional relationship network generated from Integrated Multi-Species 
Prediction (IMP) from SNP-SNP interactions associated with HDL-C after main effect 
filtering (P-value < 0.05). SNPs were mapped to their respective genes and used to query 
IMP. Nodes in the network represent genes. Orange nodes are the genes that were 
queried. Edges between nodes represent a functional relationship between two genes. The 
color of the edge signifies the strength of the relationship confidence. Known 
relationships are highlighted in gold 
 
Fig. 3 Functional relationship network generated from Integrated Multi-Species 
Prediction (IMP) from SNP-SNP interactions associated with LDL-C after main effect 
filtering (P-value < 0.05). SNPs were mapped to their respective genes and used to query 
IMP. Nodes in the network represent genes. Orange nodes are the genes that were 
queried. Edges between nodes represent a functional relationship between two genes. The 
color of the edge signifies the strength of the relationship confidence. Known 
relationships are highlighted in gold 
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Fig. 4 Schematic design of study for the QMDR lipid traits association analysis 
 
Supporting Information 
 
Fig. S1 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with LDL cholesterol 
level. LD diagram was generated using Haploview 
 
Fig. S2 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with total cholesterol level. 
LD diagram was generated using Haploview 
 
Fig. S3 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with triglyceride level. LD 
diagram was generated using Haploview 
 
Fig. S4 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with HDL cholesterol level. LD 
diagram showing r2 values was generated using Haploview 
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Fig. S5 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with LDL cholesterol level. LD 
diagram showing r2 values was generated using Haploview 
 
Fig. S6 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with total cholesterol level. LD 
diagram showing r2 values was generated using Haploview 
 
Fig. S7 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with triglyceride level. LD 
diagram showing r2 values was generated using Haploview 
 
Table S1 Known biological roles of genes identified within SNP-SNP interactions 
associated with each lipid trait. Gene information found using GeneCards database 
(www.genecards.org, Accessed March 28, 2015) 
 
Table S2 Information for cohorts providing individual level data 
 
Table S3 Information of eMERGE cohorts providing individual level data for replication 
analyses 
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Table S4 Number of original (non-proxy) and LD-expanded (proxy) SNP-SNP models 
tested for replication in eMERGE dataset. Numbers are shown for each lipid trait after 
using both filtering methods 
 
Table S5 Number of LD-expanded (proxy) SNP-SNP models generated for each original 
discovered SNP-SNP model. Also shown are the number of SNP-SNP models tested for 
replication in eMERGE dataset per signal. Numbers are shown for each lipid trait after 
using both main effect and Biofilter filtering methods 
